Records containing: Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-03-24
Chidamide-based Combination With PD-1 Blockade: A Synergistic Strategy to Improve CAR-T Cell Therapy Outcomes for B-cell Lymphoma.
CLINICAL_TRIALS study record update · 2021-05-12
ClinicalTrials.gov study NCT04705454